Vitamin D receptor polymorphism is associated with psoriasis

Journal of Investigative Dermatology

Volumn 112, Issue 1, 1999, Pages 113-116

  Park, Byung Soon ^a   Park, Jeong Soo ^a   Lee, Dong Youn ^a   Youn, Jai Il ^a   Kim, In Gyu ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; DNA; VITAMIN D RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PSORIASIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD;

EID: 0032903980     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00482.x     Document Type: Article

References (29)

1. Chen ML, Perez A, Sanan DK, Heinrich G, Chen TC, Holick MF: Induction of vitamin D receptor mRNA expression in psoriatic plaques correlates with clinical response to 1,25-dihydroxyvitamin D3. J Invest Dermatol 106:637-641, 1996
2. Dawson-Hughes B, Harris SS, Finneran S: Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endo Metab 80:3657-3661, 1995
3. Eisman JA: Vitamin D receptor gene allels and osteoporosis: an affirmative view. J Bone Miner Res 10:1289-1293, 1995
4. Elder JT, Henseler T, Christophers E, Voorhees JJ, Nair PR: Of genes and antigens: the inheritance of psoriasis. J Invest Dermatol 103:150S-153S, 1994a
5. Elder JT, Nair PR, Guo SW, Henseler T, Christophers E, Voorhees JJ: The genetics of psoriasis. Arch Dermatol 130:216-224, 1994b
6. Henseler T: The genetics of psoriasis. J Am Acad Dermatol 37:S1-S11, 1997
7. Henseler T, Christophers E: Psoriasis of early and late onset: Characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 13:450-456, 1985
8. Hoehler T, Kruger A, Schneider PM, et al: A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol 109:562-565, 1997
9. Holick MF, Chen ML, Kong XF, Sanan DK: Clinical uses for calcipotropic hormones 1,25-dihydroxyvitamin D3 and parathyroid hormone-related peptide in dermatology: a new perspective. J Invest Dermatol Symp Proc 1:1-9, 1996
10. Kontula K, Valimaki S, Kainulainen K, Viitanen A-M, Keski-Oja J: Vitamin D receptor polymorphism and treatment of psoriasis with calcipotriol. Br J Dermatol 136:977-978, 1997
11. Kragballe K: Psoriasis and other skin diseases. In: Feldman D, Glorieux FH, Pike JW (eds). Vitamin D. New York: Academic Press, 1997, pp. 1213-1226
12. Kragballe K, Gjertsen B, DeHoop D, Karlsmark T, van De Kerkhof P, Larko O: Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 337:193-196, 1991
13. Krueger GG, Bergstresser PR, Nicholas JL, Voorhees JJ: Psoriasis. J Am Acad Dermatol 11:937-947, 1984
14. Lander ES, Schork NJ: Genetic dissection of complex traits. Science 265:2037-2048, 1994
15. MacLaughlin JA, Gange W, Taylor D, Smith E, Holick MF: Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3. Proc Natl. Acad Sci USA 82:5409-5412, 1985
16. Morrison NA, Yeoman R, Kelly PJ, Eisman JA: Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci USA 89:6665-6669, 1992
17. Morrison NA, Qi JC, Tokita A, et al: Prediction of bone density from vitamin D receptor alleles. Nature 367:284-287, 1994
18. Ortonne JP: Aetiology and pathogenesis of psoriasis. Br J Dermatol 135 (Suppl. 49): 1-5, 1996
19. Reichel H, Koeffler HP, Norman AW: The role of the vitamin D endocrine system in health and disease. N Engl J Med 320:981-984, 1989
20. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, 2nd edn. New York: Cold Spring Harbor Laboratory Press, 1989
21. Sølvsten H, Fogh K, Svendsen M, Kristensen P, Astroem A, Kumar R, Kragballe K: Normal levels of the vitamin D receptor and its message in psoriatic skin. J Invest Dermatol Symp Proc 1:28-33, 1996
22. Smith EL, Walworth NC, Holick MF: Effect of 1,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 86:709-714, 1986
23. Smith EL, Pincus SH, Donovan L, Holick MF: A novel approach for the evaluation and treatment of psoriasis: oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis. J Am Acad Dermatol 19:516-528, 1988
24. Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: the insulin gene region and insulin-independent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516, 1993
25. Tarlow JK, Cork MJ, Clay FE, et al: Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasis. Br J Dermatol 136:147-148, 1997
26. Taylor JA, Hirvonen A, Watson M, Pittaman G, Mohler JL, Bell DA: Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res 56:4108-4110, 1996
27. Thomson G, Bodmer WF. The genetic analysis of HLA and disease association. In: Dausset J, Svejgaard A (eds). HLA and Disease. Copenhagen: Munksgaard, 1977, pp. 84-93
28. Tokita A, Matsumota H, Morrison NA, et al: Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. J Bone Miner Res 11:1003-1009, 1996
29. Zhao X, Feldman D: Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells. Endocrinol 132:1808-1814, 1993